Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Capital Expenditures (2016 - 2025)

CV Sciences (CVSI) has disclosed Capital Expenditures for 11 consecutive years, with $9000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 50.0% to $9000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $109000.0 through Dec 2025, up 505.56% year-over-year, with the annual reading at $109000.0 for FY2025, 505.56% up from the prior year.
  • Capital Expenditures hit $9000.0 in Q4 2025 for CV Sciences, down from $11000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $49000.0 in Q2 2025 to a low of $9000.0 in Q4 2025.
  • Historically, Capital Expenditures has averaged $27000.0 across 3 years, with a median of $26500.0 in 2021.
  • Biggest five-year swings in Capital Expenditures: tumbled 53.95% in 2021 and later crashed 50.0% in 2025.
  • Year by year, Capital Expenditures stood at $35000.0 in 2021, then crashed by 48.57% to $18000.0 in 2024, then plummeted by 50.0% to $9000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CVSI at $9000.0 in Q4 2025, $11000.0 in Q3 2025, and $49000.0 in Q2 2025.